Riskpilot← Back to searchSign inGet full accessANNA C-TRUS AS
ASActiveOrg 812633082Munkengveien 5A, 0376 OsloMedical specialists activities · NACE 8622Est. 20130 employees
Revenue 2021
NOK 0
EBITDA margin
—
-3% vs 2020
Equity ratio
82.6%
Financial strength
Net profit 2021
NOK -29K
-3% vs 2020
| Revenue | NOK 0 | — |
| EBITDA | NOK -29K | -3% |
| Net profit | NOK -29K | -3% |
| Total assets | NOK 75K | -19% |
| Equity | NOK 62K | -32% |
| Employees | 0 | — |
Legal name
ANNA C-TRUS AS
Org number
812633082
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
28. oktober 2013
Share capital
NOK 356 297 800
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Diagnose og behandling av kreft, rådgivning og deltakelse i andre virksomheter.
Address
Munkengveien 5A, 0376 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2 299 | 1 022 | 116 | 782 | 982 | 30 | 0 | 0 |
| Staff expenses | −1 172 | −742 | −320 | −1 186 | −1 167 | −292 | −0 | −0 |
| EBITDA | 150 | −235 | −771 | −787 | −589 | −346 | −28 | −29 |
| Depreciation & amort. | −74 | −155 | −59 | −18 | 4 | −0 | −0 | −0 |
| EBIT | 76 | −390 | −830 | −805 | −585 | −346 | −28 | −29 |
| Net financials | −44 | −182 | −273 | −46 | −24 | −4 | 0 | 0 |
| Profit before tax | 32 | −571 | −1 103 | −851 | −608 | −350 | −28 | −29 |
| Tax | 11 | −11 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 21 | −560 | −1 103 | −851 | −608 | −350 | −28 | −29 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 9 487 | 11 305 | 10 859 | 1 014 | 596 | 118 | 92 | 75 |
| Equity | 57 | −503 | −1 606 | −2 457 | −3 065 | 118 | 90 | 62 |
| Long-term debt | 9 041 | 11 712 | 12 252 | 3 240 | 3 375 | 0 | 0 | 0 |
| Short-term debt | 388 | 96 | 213 | 231 | 286 | 0 | 1 | 13 |
| Total debt | 9 429 | 11 808 | 12 465 | 3 471 | 3 661 | 0 | 1 | 13 |
EBITDA margin
-2858400.0%
This company
15.8%
Market median
-18091239% vs market
20142021
Equity ratio
82.6%
This company
38.2%
Market median
+116% vs market
20142021
Return on equity
-46.3%
This company
18.4%
Market median
-352% vs market
20142021
Net profit margin
-2858400.0%
This company
8.1%
Market median
-35288989% vs market
20142021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20142021
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20142021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — | |
| Board of Directors | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ANNA C-TRUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gard Lauvsnes | Chairman | 0 companies |
| Ole Mjåtvedt | Board of Directors | 0 companies |